Advertisement
Advertisement

Barclays: $7 billion worth of securities sold in error have been claimed

By:
Reuters
Updated: Sep 15, 2022, 19:36 GMT+00:00

LONDON (Reuters) - Barclays said investors have submitted claims for $7 billion out of $17.7 billion worth of securities it sold in error, under the terms of a so-called rescission offer by which the bank had to buy back the notes and compensate buyers.

The logo of Barclays bank is seen on glass lamps outside of a branch of the bank in the City of London financial district in London

LONDON (Reuters) – Barclays said investors have submitted claims for $7 billion out of $17.7 billion worth of securities it sold in error, under the terms of a so-called rescission offer by which the bank had to buy back the notes and compensate buyers.

The British bank said it was evaluating the overall financial impact of the offer, and will provide an update in due course.

The problem dates back to March 28 when Barclays disclosed it had oversold a range of complex structured and exchange-traded notes, overshooting by about 75% a $20.8 billion limit agreed with United States regulators.

Buyers of the notes, considered “unregistered securities” under U.S. law, had the right to demand Barclays buy back the investments at the original price plus interest.

The bank’s second quarter earnings were dented by a 580 million pound ($667.58 million) net hit from the blunder, after charges for the expected costs of fixing the mistake were somewhat mitigated by hedges the bank put in place against such costs.

($1 = 0.8688 pounds)

(Reporting By Lawrence White; Editing by Tomasz Janowski)

About the Author

Reuterscontributor

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products:

Did you find this article useful?
Advertisement